Envisagenics’ Post

🚀 Our datasets are growing! 📈 OmicsChart are dedicated to making it easier for translational biologists to obtain insights from patient-derived cancer data. 🧬💻 Curious to see how OmicsChart can your support your research? Reach out to one of our founders or ✉ sales@omicschart.com to schedule a personalized demo. 🤝 Tanya Aneichyk Asta Vasalauskaite, PhD #OmicsChart #CancerResearch #DataAnalytics #InnovationInHealthcare #oncology #BiomarkerDiscovery #CancerResearch #PrecisionOncology #rwd #realworlddata #cancerbiology #precisionmedicine #oncologyresearch #bioinformatics #computationalbiology #biotech #multiomics #transcriptomics #genomics #omics #rnatherapeutics #immunooncology #startup #techbio

Next-Generation Sequencing (NGS) technologies are revolutionizing our ability to study genomes, transforming fields from medicine to agriculture. NGS is showing particular promise in the field of oncology, revolutionizing cancer diagnostics and treatments as it reveals specific genetic mutations that drive a patient’s cancer. As technology evolves, sequencing may soon become a part of routine medical care, unlocking a new era of predictive and preventative medicine. In our recent blog, we explore how sequencing technologies have evolved over time – discover where we’ve come from and what the future might hold: https://hubs.ly/Q02Gm4W40 #NextGenerationSequencing #NGS #Biotechnology #Sequencing #Genomics #Oncology #BiotechMarketing

🔬 CAR-T cell therapies are evolving with advanced #CRISPR Prime Editing! Dr. Karl Petri's Prime-CAR Inspection project, backed by the DFG, aims to overcome current challenges in cancer treatment by making CAR-T cells more efficient and safer. Discover more: [Link]: https://lnkd.in/dGeeNPAv Dr. Karl Petri of the University Hospital Würzburg is using advanced CRISPR Prime Editing to enhance CAR-T cell therapies, aiming to address challenges such as the lack of effective treatments for solid tumors and the durability of remissions. Supported by the German Research Foundation, the Prime-CAR Inspection project focuses on precise genome modifications and safety validation to improve cancer-directed immunotherapies. #CRISPR #CARTcell #Genetics #Biotech #CancerResearch #MedicalInnovation #PrimeEditing #DFG #Immunotherapy #ScienceBreakthroughs #CancerResearch #Biotech #MedicalInnovation

For anyone in my network traveling to Barcelona next week for #ESMO24, stop by Booth #422 if you're looking to have a deep dive into how real-world data (DNA-seq + RNA-seq + whole slide images + linked longitudinal treatment and outcomes data) can power your clinical pipelines. 🌐 With access to 200k+ tumor biopsies, Tempus is transforming cancer research with multimodal data, including genomic, transcriptomic, and imaging insights. From novel target discovery to biomarker development and companion diagnostics, we are driving critical decisions that accelerate drug development. Our capabilities span across: 🔹 Real-world DNA, RNA, imaging, longitudinal clinical data 🔹 Validating biomarkers with tumor-derived organoids 🔹 Supporting clinical trial design with real-world data 🔹 Companion diagnostic development using broad-panel NGS assays 🔹 Evidence generation for label expansion Come by to discuss how Tempus data can supercharge your research. Or just stop by for a chat! See you in Barcelona! 🇪🇸 #Oncology #ClinicalTrials #RealWorldData #PrecisionMedicine #DrugDevelopment #ESMO2024 #Biotech #Tempus

🌟 Learn. Innovate. Push the boundaries of what's possible. 🌟 In our ever-evolving world, I’m constantly reminded of the importance of staying curious and adaptable. Whether it’s exploring new technologies, diving into recent research, or simply asking, “What if?”, these daily challenges drive us to find creative solutions to complex problems. Did you know there are now more than 300 oncology drugs in development, each with the potential to significantly change how we treat cancer? And that sometimes the most profound solutions come from the most unexpected places—like a sea squirt (also known as ascidian)! Ascidian Therapeutics is leveraging this tiny creature’s unique RNA splicing abilities to develop new treatments for retinal and neurological diseases. Embrace the unknown. Turn challenges into opportunities. #biotech #curiosity

🚀 Redefine Cell Culture with Provectus Therapeutics! 🚀 We're excited to introduce our cutting-edge technology in providing unprecedented resolution for cancer research in tumor heterogeneity, phenotypic variability and off-target mechanism. Here’s why you should partner with us: 🔬 Up to 1 Million Single Cell Culture: Achieve unprecedented resolution single cell analysis. 🤖 AI-powered Single Cell Analysis: Leverage the power of AI for detailed and accurate single cell analysis. 💊  Drug Responses : Extract over 180 morphological and phenotypic features from each cancer cell for multidimensional analysis (i.e. multiomics, morphology and cell viability). Ready to take your cancer research to the next level? Connect with us today to explore collaboration opportunities! 🌐 [https://lnkd.in/gpPZVfjx] ✉️ [business@provectustherapeutics.com] #CancerResearch #CellCulture #DrugDevelopment #AIinHealthcare #Biotechnology #ResearchCollaboration

Provectus Therapeutics has developed a cost-effective, advanced culture plate designed for single cell culture and analysis. This platform is ideal for studying tumor heterogeneity, phenotypic plasticity, and off-target mechanisms in oncology. Visit the post below for more details! #AI #cancer #drugdevelopment #precisionmedicine

Our genomics experts will be attending the Vizgen & Labroots webinar on July 25th to dive deeper into Spatial Transcriptomics. We'll explore: • Interactions between cell types like cancer, immune cells, fibroblasts, and endothelial cells. • How Spatial Transcriptomics maps gene expression within tissue sections for a detailed view of gene activity. • Insights into tumor evolution, immune evasion, and therapeutic resistance. Stay tuned for key takeaways and how our experts can leverage these insights to drive your research forward!

It's always exciting to meet and collaborate with brilliant minds who drive innovation forward. Was a pleasure meeting Dr. Istvan Petak, MD, PhD- Founder, CEO and CSO of Genomate Health, a novel computational method for standardized, personalized treatment recommendations, that has won numerous recognitions from prestigious organizations such as ASCO. Dr. Petak is an international expert in precision oncology and molecular pharmacology of targeted therapies and has played a pivotal role in research on apoptotic pathways in individual drug sensitivity, pioneered molecular companion diagnostics of EGFR gene and implementation of NGS (next-generation sequencing) in precision oncology. #precisionmedicine #oncology #innovation

Interested to know how spatial transcriptomics can uncover the tumor microenvironment, leading to biomarker discovery for developing effective immunotherapies? Check out Vizgen's webinar on 25 July!